Savvy Updates, 7/13/20: Medtronic + Tandem Cross-Patent Deal, Insulin Sensors
Medtronic inks cross license deal with Tandem Diabetes Care, as reported on 0 July 2020. Medtronic plc and Tandem Diabetes Care today announced that they have entered into a non-exclusive patent cross-license agreement for certain technologies in the field of...
Savvy Updates, 6/22/20: New Faster Lilly Insulin (Lyumjev), Freestyle Libre 2, Weekly Basal Insulin, Celiac T1D, Non-Insulin Therapies
FDA approves novel, faster-acting insulin lispro injection was reported by Regina Schaffer for HealioNews.com/Endocrinology, 16 June 2020. Insulin lispro-aabc injection 100 U/mL and 200 U/mL (Lyumjev) is a novel formulation of insulin lispro, developed to speed...
Savvy Updates, 6/15/20: Inhalable Insulin Fewer Lows, Medtronic’s $337 Million Product Investment, T1D Wisdom in Pandemic
Hypoglycemia Is Reduced With Use of Inhaled Insulin Relative to Insulin Aspart in T1D A study found that participants treated with Afrezza experienced significantly fewer hypoglycemic events than participants treated with insulin aspart. Additionally, this reduction...
Savvy Updates, 6/8/20: Sea Snail Venom Fast Insulin?, Statins/Insulin Resistance, “Smart” Insulin Pens, Omnipod Horizon, Bad Insulin?, Nasal Glucagon
Sea snail venom used to create a new type of insulin was reported by Ryan Morrison for the DailyMail.co.uk, 1 June 2020. Insulin developed from the venom of a predatory sea snail could be used to create a ‘safer and more effective’ diabetes treatment,...
Savvy Updates, 6/1/20: Insulin Coupons, Less HbA1c variability with pump over MDI, Student invention for MDI
Why Insulin Coupons & CoPay Caps Aren’t Good Enough was reported by Ginger Vieira for InsulinNation.com, 28 May 2020. Novo Nordisk, Sanofi, and Eli Lilly reacted to insulin pricing outrage with modest and self-serving PR programs that do little; CMS is...
More Diabetes Blogs